Literature DB >> 2919132

Delayed lung maturation in the macrosomic offspring of genetically determined diabetic (db/+) mice.

S Lawrence1, J Warshaw, H C Nielsen.   

Abstract

We studied a genetically determined diabetes in pregnancy, the heterozygous diabetes (db/+) mouse. We found that fetal mice from these pregnancies are macrosomic with increased body, lung, and placenta wt, have altered organ protein, DNA and phospholipid content, and exhibit abnormal carbohydrate metabolism with increased liver and glycogen content. We further studied the effect of increased substrate availability and utilization on lung growth and maturation in (db/+) fetal mice, by measuring lung phospholipid synthesis as represented by the incorporation of the radiolabeled precursors, [3H]choline and [14C]glycerol, in fetal lung at 18 days' gestation (term = 19). Diabetic fetuses incorporated significantly more [3H]choline into disaturated phosphatidylcholine than controls (1.32 +/- 0.10 X 10(-2) versus 0.78 +/- 0.05 X 10(-2) nmol/g protein/min, mean +/- SE; p less than 0.001), but significantly less [14C]glycerol into phosphatidylglycerol than controls (3.18 +/- 0.38 versus 4.91 +/- 0.53 nmol/g protein/min, mean +/- SE; p less than 0.002), and their phosphatidylglycerol/phosphatidylinositol synthesis ratios were decreased (1.81 +/- 0.18 versus 3.17 +/- 0.14; mean +/- SE; p less than 0.001). Diabetic fetal lungs appeared morphologically less mature than controls at 18 days' gestation, as shown by a significantly decreased air space density (0.27 +/- 0.01 versus 0.43 +/- 0.02, mean +/- SE; p less than 0.001) and alveolar epithelial cell/total tissue ratio (0.54 +/- 0.02 versus 0.66 +/- 0.03, mean +/- SE; p less than 0.01). The increased synthesis of lung disaturated phosphatidylcholine in diabetic fetal mice may reflect the enhancement of body and lung growth in these macrosomic fetuses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2919132     DOI: 10.1203/00006450-198902000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Altered contribution of RhoA/Rho kinase signaling in contractile activity of myometrium in leptin receptor-deficient mice.

Authors:  Jeremy S Harrod; Cara C Rada; Stephanie L Pierce; Sarah K England; Kathryn G Lamping
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

2.  Hypoxia-reoxygenation treatment attenuates gestational diabetes mellitus.

Authors:  Xiuzhen Hou; Junfeng Zhang; Hehong Ma; Ming Li; Pei Wang
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

3.  Importance of maternal diabetes on the chronological deregulation of the intrauterine development: an experimental study in rat.

Authors:  Marcela Salazar García; Elba Reyes Maldonado; María Cristina Revilla Monsalve; Laura Villavicencio Guzmán; Alfonso Reyes López; Concepción Sánchez-Gómez
Journal:  J Diabetes Res       Date:  2015-02-09       Impact factor: 4.011

4.  Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK.

Authors:  Liangqi Yao; Jipeng Wan; Hongyan Li; Jian Ding; Yanyun Wang; Xietong Wang; Mingjiang Li
Journal:  Reprod Biol Endocrinol       Date:  2015-11-05       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.